Edgewise Therapeutics Inc
EWTX
Market Cap$1.53B
Close$
$0.40
97.3% downside
Current Fair Value
97.3% downsideOvervalued by 97.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.53 Billion |
|---|---|
| Enterprise Value | $1.50 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.45 |
| Beta | 0.37 |
| Outstanding Shares | 92,414,626 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -10.07 |
|---|---|
| PEG | -30.76 |
| Price to Sales | - |
| Price to Book Ratio | 3.72 |
| Enterprise Value to Revenue | 664.31 |
| Enterprise Value to EBIT | -10.17 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Edgewise Therapeutics Inc
19 employeesEdgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need....